PepGen Ltd (PEPG)
Healthcare
Biotechnology
1.90 $
+6.8%
vs. previous close
Closing price · As of: 3. Aug 2026
PepGen Ltd (PEPG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -82 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.9 | -1.7 | -23 | -59 | -69 | -82 | -82 | |
| 0.1 | 0.1 | 0.2 | 0.5 | 0.9 | 5.3 | 5.1 | |
| – | 0.1 | 1.5 | 4.8 | 7.0 | 11 | 11 | |
| 0.1 | 0.1 | 1.7 | 4.8 | – | – | – | |
| 0.3 | 0.0 | 2.8 | 4.5 | 2.0 | -5.2 | -6.2 | |
| 0.0 | 0.0 | 0.5 | 3.8 | 2.6 | 0.5 | 0.3 | |
| 0.0 | 0.0 | -0.5 | -3.8 | -32 | -38 | -15 | |
| – | – | – | 115 | – | – | – | |
| 2.8 | 8.0 | 148 | 112 | -0.2 | 89 | 108 | |
| 1.9 | 6.3 | 125 | 49 | -101 | -31 | 11 | |
| -0.9 | -1.7 | -23 | -63 | -72 | -83 | -82 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.